18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System, Eur J Nucl Med Mol Imaging, vol.46, pp.107-122, 2019. ,
Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective singlecenter evaluation, Eur J Nucl Med Mol Imaging, vol.46, pp.116-144, 2019. ,
Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group, J Clin Oncol, vol.32, pp.3048-58, 2014. ,
Role of (18)F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group, Lancet Oncol, vol.18, pp.206-223, 2017. ,
PET imaging for initial staging and therapy assessment in multiple myeloma patients, Int J Mol Sci, vol.18, p.445, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-01500327
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma, Blood, vol.114, pp.2068-76, 2009. ,
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation, Blood, vol.118, pp.5989-95, 2011. ,
Prospective evaluation of magnetic resonance imaging and [(18)F]fluorodeoxyglucose positron emission tomographycomputed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM/DFCI 2009 trial: results of the IMAJEM study, J Clin Oncol, vol.35, pp.2911-2919, 2017. ,
Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation, Eur J Nucl Med Mol Imaging, vol.45, pp.1694-704, 2018. ,
Utility and prognostic value of 18F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma, Am J Hematol, vol.93, pp.1518-1541, 2018. ,
Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing, Nat Commun, vol.8, p.268, 2017. ,
Extramedullary multiple myeloma, Leuk Lymphoma, vol.54, pp.1135-1176, 2013. ,
How I treat extramedullary myeloma, Blood, vol.127, pp.971-977, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01411096
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma, Lancet Oncol, vol.17, pp.328-374, 2016. ,
The value of 18F-FDG PET/CT after autologous stem cell transplantation (ASCT) in patients affected by multiple myeloma (MM): experience with 77 patients, Clin Nucl Med, vol.38, pp.74-83, 2013. ,
PET/CT improves the definition of complete response and allows to detect otherwise unidentifiable skeletal progression in multiple myeloma, Clin Cancer Res, vol.21, pp.4384-90, 2015. ,
Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement, J Clin Oncol, vol.33, pp.657-64, 2015. ,
Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian myeloma criteria for PET USe), Eur J Nucl Med Mol Imaging, vol.43, pp.414-435, 2016. ,
Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe), Eur J Nucl Med Mol Imaging, vol.45, pp.712-721, 2018. ,
State-of-the-art and recent advances in quantification for therapeutic follow-up in oncology using PET, Front Med (Lausanne), vol.2, p.18, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01817854
Interim PET analysis in first-line therapy of multiple myeloma: prognostic value of ?SUVmax in the FDG-avid patients of the IMAJEM study, Clin Cancer Res, vol.24, pp.5219-5243, 2018. ,
Reproducibility of metabolic measurements in malignant tumors using FDG PET, J Nucl Med, vol.40, pp.1771-1778, 1999. ,
Report of the 6th International Workshop on PET in lymphoma, Leuk Lymphoma, vol.58, pp.2298-303, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01742975
Standardization of 18F-FDG PET/CT according to Deauville criteria for MRD evaluation in newly diagnosed transplant eligible multiple myeloma patients: joined analysis of two prospective randomized phase III trials, Blood, vol.132, p.257, 2018. ,